Evaluation of risk for late language emergence after in utero antiretroviral drug exposure in HIV-exposed uninfected infants
- PMID: 24067563
- PMCID: PMC3785009
- DOI: 10.1097/INF.0b013e31829b80ee
Evaluation of risk for late language emergence after in utero antiretroviral drug exposure in HIV-exposed uninfected infants
Abstract
Background: Combination antiretroviral (cARV) regimens are recommended for pregnant women with HIV to prevent perinatal HIV transmission. Safety is a concern for infants who were HIV-exposed but uninfected, particularly for neurodevelopmental problems, such as language delays.
Methods: We studied late language emergence (LLE) in HIV-exposed but uninfected children enrolled in a US-based prospective cohort study. LLE was defined as a caregiver-reported score ≤10th percentile in any of 4 domains of the MacArthur-Bates Communicative Development Inventory for 1-year olds and as ≥1 standard deviation below age-specific norms for the Ages and Stages Questionnaire for 2-year olds. Logistic regression models were used to evaluate associations of in utero cARV exposure with LLE, adjusting for infant, maternal and environmental characteristics.
Results: 1129 language assessments were conducted among 792 1- and 2-year-old children (50% male, 62% black and 37% Hispanic). Overall, 86% had in utero exposure to cARV and 83% to protease inhibitors. LLE was identified in 26% of 1-year olds and 23% of 2-year olds, with higher rates among boys. In adjusted models, LLE was not associated with maternal cARV or ARV drug classes in either age group. Among cARV-exposed 1-year olds, increased odds of LLE was observed for those exposed to atazanavir (adjusted odds ratio = 1.83, 95% confidence interval: 1.10-3.04), particularly after the first trimester (adjusted odds ratio = 3.56, P = 0.001), compared with atazanavir-unexposed infants. No associations of individual ARV drugs with LLE were observed among 2-year olds.
Conclusions: In utero cARV exposure showed little association with LLE, except for a higher risk of language delay observed in 1-year-old infants with atazanavir exposure.
Figures
Similar articles
-
Congenital anomalies and in utero antiretroviral exposure in human immunodeficiency virus-exposed uninfected infants.JAMA Pediatr. 2015 Jan;169(1):48-55. doi: 10.1001/jamapediatrics.2014.1889. JAMA Pediatr. 2015. PMID: 25383770 Free PMC article.
-
Meconium Atazanavir Concentrations and Early Language Outcomes in HIV-Exposed Uninfected Infants With Prenatal Atazanavir Exposure.J Acquir Immune Defic Syndr. 2015 Jun 1;69(2):178-86. doi: 10.1097/QAI.0000000000000558. J Acquir Immune Defic Syndr. 2015. PMID: 26009830 Free PMC article.
-
Safety of perinatal exposure to antiretroviral medications: developmental outcomes in infants.Pediatr Infect Dis J. 2013 Jun;32(6):648-55. doi: 10.1097/INF.0b013e318284129a. Pediatr Infect Dis J. 2013. PMID: 23340561 Free PMC article.
-
The PHACS SMARTT Study: Assessment of the Safety of In Utero Exposure to Antiretroviral Drugs.Front Immunol. 2016 May 23;7:199. doi: 10.3389/fimmu.2016.00199. eCollection 2016. Front Immunol. 2016. PMID: 27242802 Free PMC article. Review.
-
Neurodevelopment in children born to HIV-infected mothers by infection and treatment status.Pediatrics. 2012 Nov;130(5):e1326-44. doi: 10.1542/peds.2012-0405. Epub 2012 Oct 1. Pediatrics. 2012. PMID: 23118140 Review.
Cited by
-
Pediatric Neurodevelopmental Functioning After In Utero Exposure to Triple-NRTI vs. Dual-NRTI + PI ART in a Randomized Trial, Botswana.J Acquir Immune Defic Syndr. 2018 Nov 1;79(3):e93-e100. doi: 10.1097/QAI.0000000000001799. J Acquir Immune Defic Syndr. 2018. PMID: 30015793 Free PMC article. Clinical Trial.
-
Risk factors affecting child cognitive development: a summary of nutrition, environment, and maternal-child interaction indicators for sub-Saharan Africa.J Dev Orig Health Dis. 2016 Apr;7(2):197-217. doi: 10.1017/S2040174415001427. Epub 2015 Sep 11. J Dev Orig Health Dis. 2016. PMID: 26358240 Free PMC article.
-
Hearing Loss in Offspring Exposed to Antiretrovirals During Pregnancy and Breastfeeding.Front Mol Neurosci. 2022 Jun 20;15:920528. doi: 10.3389/fnmol.2022.920528. eCollection 2022. Front Mol Neurosci. 2022. PMID: 35795690 Free PMC article.
-
In Utero Antiretroviral Exposure and Risk of Neurodevelopmental Problems in HIV-Exposed Uninfected 5-Year-Old Children.AIDS Patient Care STDS. 2023 Mar;37(3):119-130. doi: 10.1089/apc.2022.0189. Epub 2023 Feb 24. AIDS Patient Care STDS. 2023. PMID: 36827595 Free PMC article.
-
Perinatal exposure to atazanavir-based antiretroviral regimens in a mouse model leads to differential long-term motor and cognitive deficits dependent on the NRTI backbone.Front Mol Neurosci. 2024 Apr 5;17:1376681. doi: 10.3389/fnmol.2024.1376681. eCollection 2024. Front Mol Neurosci. 2024. PMID: 38646101 Free PMC article.
References
-
- Reilly S, Bavin EL, Bretherton L, et al. The Early Language in Victoria Study (ELVS): A prospective, longitudinal study of communication skills and expressive vocabulary development at 8, 12 and 24 months. International Journal of Speech-Language Pathology. 2009;11(5):344–357.
-
- Feldman HM, Dollaghan CA, Campbell TF, Kurs-Lasky M, Janosky JE, Paradise JL. Measurement properties of the MacArthur Communicative Development Inventories at ages one and two years. Child Dev. 2000;71(2):310–322. - PubMed
-
- Quigley MA, Poulsen G, Boyle E, et al. Archives of Disease in Children: Fetal & Neonatal Edition. 2011. Early term and late preterm birth are associated with poorer school performance at age 5 years: a cohort study. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical